- Home
- ATAI vs BARK Comparison
ATAI vs BARK Comparison
Compare ATAI & BARK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATAI
- BARK
- Stock Information
- Founded
- ATAI 2018
- BARK 2011
- Country
- ATAI Germany
- BARK United States
- Employees
- ATAI N/A
- BARK N/A
- Industry
- ATAI Biotechnology: Pharmaceutical Preparations
- BARK Department/Specialty Retail Stores
- Sector
- ATAI Health Care
- BARK Consumer Discretionary
- Exchange
- ATAI Nasdaq
- BARK Nasdaq
- Market Cap
- ATAI 291.5M
- BARK 342.7M
- IPO Year
- ATAI 2021
- BARK N/A
- Fundamental
- Price
- ATAI $1.24
- BARK $1.43
- Analyst Decision
- ATAI Strong Buy
- BARK Buy
- Analyst Count
- ATAI 4
- BARK 2
- Target Price
- ATAI $9.00
- BARK $2.50
- AVG Volume (30 Days)
- ATAI 1.7M
- BARK 804.3K
- Earning Date
- ATAI 03-17-2025
- BARK 02-05-2025
- Dividend Yield
- ATAI N/A
- BARK N/A
- EPS Growth
- ATAI N/A
- BARK N/A
- EPS
- ATAI N/A
- BARK N/A
- Revenue
- ATAI $308,000.00
- BARK $490,256,000.00
- Revenue This Year
- ATAI N/A
- BARK $3.12
- Revenue Next Year
- ATAI $20.00
- BARK $7.76
- P/E Ratio
- ATAI N/A
- BARK N/A
- Revenue Growth
- ATAI N/A
- BARK N/A
- 52 Week Low
- ATAI $1.03
- BARK $1.01
- 52 Week High
- ATAI $2.85
- BARK $2.56
- Technical
- Relative Strength Index (RSI)
- ATAI 36.74
- BARK 42.08
- Support Level
- ATAI $1.42
- BARK $1.34
- Resistance Level
- ATAI $1.58
- BARK $1.48
- Average True Range (ATR)
- ATAI 0.12
- BARK 0.08
- MACD
- ATAI -0.00
- BARK 0.02
- Stochastic Oscillator
- ATAI 4.55
- BARK 70.59
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.
About BARK BARK Inc.
BARK Inc is a vertically integrated, omnichannel brand serving dogs across two key categories: toys & accessories and consumables. It serves dogs nationwide with monthly subscription services, BarkBox and Super Chewer; e-commerce experience on BarkShop.com; custom collections via its retail partner network, including Target and Amazon; wellness products that meet dogs' needs with BARK Bright; and a personalized meal delivery service for dogs BARK Eats. The company's reportable segments are; Direct to Consumer (D2C), and Commerce. The majority of its revenue is generated from the Direct to Consumer segment which derives revenue from the sale of toys & accessories and consumables through BarkBox, Super Chewer, and the company's consumables website.